There is growing evidence that ALKBH5 is an essential regulator of tumor progression and is involved in the malignant progression of several tumor types,24 including breast cancer,25 GBM,26 and acute myeloid leukemia,27 by demethylating m6A‐modified mRNA. Here, ALKBH5 is linked to neoplasm.